Equity Method Investments (Tables)

12 Months Ended

Sep. 03, 2015

Equity Method Investments and Joint Ventures [Abstract]

Equity Method Investments

As of	2015				2014
	Investment Balance		Ownership Percentage		Investment Balance		Ownership Percentage
Inotera(1)	$	1,332	33	%	$	914	33	%
Tera Probe	38		40	%	48		40	%
Other	9		Various		9		Various
	$	1,379			$	971

⁽¹⁾ Entity is a variable interest entity.

As of September 3, 2015, substantially all of our maximum exposure to loss from our VIEs that were not consolidated was the $1.33 billion carrying value of our investment in Inotera.  We may also incur losses in connection with our rights and obligations to purchase all of Inotera's wafer production capacity under our supply agreements with Inotera.

We recognize our share of earnings or losses from our equity method investees generally on a two-month lag.  Our share of earnings for 2015 included $49 million for the net effect of Inotera's full release of its valuation allowance against net deferred tax assets related to its net operating loss carryforward and the resulting tax provision in subsequent periods. Equity in net income (loss) of equity method investees, net of tax, included the following:

For the year ended	2015		2014			2013
Inotera	$	445	$	465		$	(79	)
Tera Probe	1		11			—
Other	1		(2		)	(4		)
	$	447	$	474		$	(83	)

The summarized financial information in the tables below reflects aggregate amounts for our equity method investees. Financial information is presented for equity method investments as of the respective dates and for the periods through which we recorded our proportionate share of each investee's results of operations. Summarized results of operations are presented only for the periods subsequent to the acquisition or through the disposition of our ownership interests.

As of	2015		2014
Current assets	$	1,980	$	2,233
Noncurrent assets	3,038		2,502
Current liabilities	436		1,417
Noncurrent liabilities	119		254

For the year ended	2015		2014		2013
Net sales	$	2,647	$	3,382	$	1,788
Gross margin	1,253		1,576		1
Operating income (loss)	1,191		1,371		(203		)
Net income (loss)	1,361		1,339		(188		)